OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
2700$0.6156

Green International Holdings Ltd

Healthcare Facilities & ServicesVerified

Green International Holdings Ltd has a market capitalization of HKD 402.54 million and a price-to-book ratio of 10.8, indicating a premium valuation relative to its book value. The company's debt-to-equity ratio is 0.58, suggesting a moderate level of leverage. However, the current ratio of 1.52 indicates that the company has sufficient current assets to cover its short-term liabilities. The company's profitability is weak, with a negative return on equity of -10.37% and a negative return on assets of -3.88%. These figures are below the industry median for healthcare facilities and services, which typically exhibit positive returns. The operating income of HKD 507,000 is significantly lower than the revenue of HKD 54.31 million, indicating high operating costs and low margins. The company's revenue is distributed across three segments: Health and Medical, Beauty and Wellness, and Financial Services. The Health and Medical segment operates hemodialysis centers and hospitals, while the Beauty and Wellness segment sells beauty and wellness products and services. The Financial Services segment is engaged in financial business. The input data does not provide specific revenue breakdowns for each segment. The company's growth trajectory is uncertain, with a net loss of HKD 3.87 million in the latest period. The outlook for the current fiscal year is not provided, but the negative net income suggests a challenging operating environment. The company's revenue of HKD 54.31 million is a key metric to monitor for future performance. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company has a negative net cash position after subtracting total debt, which could impact its ability to meet short-term obligations. The valuation adjustments applied in the custom valuations do not indicate significant dilution potential. Recent events and filings have not been provided in the input data, so no specific recent developments can be cited. The company's financial health and operational performance will need to be closely monitored for any material changes.

30-day price · 2700+0.01 (+1.7%)
Low$0.50High$0.69Close$0.61As of21 May, 00:00 UTC
Profile
CompanyGreen International Holdings Ltd
Ticker2700.HK
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Green International Holdings Ltd operates in the healthcare sector, providing beauty and wellness services through three segments: Health and Medical, Beauty and Wellness, and Financial Services.

Classification. The company is classified under the Healthcare economic sector, Healthcare Services & Equipment business sector, and Healthcare Facilities & Services industry with a confidence level of 0.92.

Green International Holdings Ltd has a market capitalization of HKD 402.54 million and a price-to-book ratio of 10.8, indicating a premium valuation relative to its book value. The company's debt-to-equity ratio is 0.58, suggesting a moderate level of leverage. However, the current ratio of 1.52 indicates that the company has sufficient current assets to cover its short-term liabilities. The company's profitability is weak, with a negative return on equity of -10.37% and a negative return on assets of -3.88%. These figures are below the industry median for healthcare facilities and services, which typically exhibit positive returns. The operating income of HKD 507,000 is significantly lower than the revenue of HKD 54.31 million, indicating high operating costs and low margins. The company's revenue is distributed across three segments: Health and Medical, Beauty and Wellness, and Financial Services. The Health and Medical segment operates hemodialysis centers and hospitals, while the Beauty and Wellness segment sells beauty and wellness products and services. The Financial Services segment is engaged in financial business. The input data does not provide specific revenue breakdowns for each segment. The company's growth trajectory is uncertain, with a net loss of HKD 3.87 million in the latest period. The outlook for the current fiscal year is not provided, but the negative net income suggests a challenging operating environment. The company's revenue of HKD 54.31 million is a key metric to monitor for future performance. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company has a negative net cash position after subtracting total debt, which could impact its ability to meet short-term obligations. The valuation adjustments applied in the custom valuations do not indicate significant dilution potential. Recent events and filings have not been provided in the input data, so no specific recent developments can be cited. The company's financial health and operational performance will need to be closely monitored for any material changes.
Key takeaways
  • The company is trading at a premium to book value with a price-to-book ratio of 10.8.
  • The company has a negative return on equity and return on assets, indicating poor profitability.
  • The company's debt-to-equity ratio is 0.58, suggesting a moderate level of leverage.
  • The company has a negative net cash position, which could impact its liquidity.
  • The company's growth trajectory is uncertain, with a net loss in the latest period.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyHKD
Revenue$54.3M
Gross profit$30.4M
Operating income$507.0k
Net income-$3.9M
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets$99.6M
Total liabilities$62.3M
Total equity$37.3M
Cash & equivalents
Long-term debt$21.6M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$54.3M$507.0k-$3.9M$2.9M
FY-1$53.0M$4.2M-$807.0k$9.9M
FY-2$48.8M-$7.1M-$10.6M-$23.0M
FY-3$47.2M-$10.5M-$13.2M-$3.5M
FY-4$69.1M-$68.9M-$69.2M-$60.2M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$99.6M$37.3M
FY-1$113.4M$39.6M
FY-2$136.2M$41.2M
FY-3$168.6M$52.2M
FY-4$214.8M$66.3M
PeriodOCFCapExFCFSBC
FY0-$2.6M-$2.5M$2.9M
FY-1$4.4M-$2.1M$9.9M
FY-2$22.6M-$23.9M-$23.0M
FY-3-$12.8M-$357.0k-$3.5M
FY-4-$1.6M-$3.7M-$60.2M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$0.61
Market cap$402.5M
Enterprise value$424.2M
P/E
Reported non-GAAP P/E
EV/Revenue7.8
EV/Op income836.6
EV/OCF
P/B10.8
P/Tangible book10.8
Tangible book$37.3M
Net cash-$21.6M
Current ratio1.5
Debt/Equity0.6
ROA-3.9%
ROE-10.4%
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Biotechnology · cohort 9 companies
Metric2700Activity
Op margin0.9%11.5% medp25 9.9% · p75 15.0%bottom quartile
Net margin-7.1%8.6% medp25 6.3% · p75 12.4%bottom quartile
Gross margin56.1%28.8% medp25 28.8% · p75 28.8%top quartile
CapEx / revenue4.2% medp25 3.8% · p75 4.2%
Debt / equity58.0%71.3% medp25 60.7% · p75 71.3%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 02:12 UTC#cc06f37e
Market quoteclose HKD 0.61 · shares 0.66B diluted
no public URL
2026-05-12 02:12 UTC#7785af18
Source: analysis-pipeline (hybrid)Generated: 2026-05-12 02:14 UTCJob: 6287278e